These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


380 related items for PubMed ID: 3552674

  • 1. Studies on the effect of serine protease inhibitors on activated contact factors. Application in amidolytic assays for factor XIIa, plasma kallikrein and factor XIa.
    Tans G, Janssen-Claessen T, Rosing J, Griffin JH.
    Eur J Biochem; 1987 May 04; 164(3):637-42. PubMed ID: 3552674
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Mechanism of surface-mediated activation of bovine Factor XII and prekallikrein.
    Sugo T, Ohno Y, Shimada T, Kato H, Iwanaga S.
    Adv Exp Med Biol; 1983 May 04; 156():87-107. PubMed ID: 6602465
    [Abstract] [Full Text] [Related]

  • 4. Active-site mapping of bovine and human blood coagulation serine proteases using synthetic peptide 4-nitroanilide and thio ester substrates.
    Cho K, Tanaka T, Cook RR, Kisiel W, Fujikawa K, Kurachi K, Powers JC.
    Biochemistry; 1984 Feb 14; 23(4):644-50. PubMed ID: 6370301
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Interaction of type 1 plasminogen activator inhibitor with the enzymes of the contact activation system.
    Berrettini M, Schleef RR, España F, Loskutoff DJ, Griffin JH.
    J Biol Chem; 1989 Jul 15; 264(20):11738-43. PubMed ID: 2787318
    [Abstract] [Full Text] [Related]

  • 8. Amidolytic assay of human factor XI in plasma: comparison with a coagulant assay and a new rapid radioimmunoassay.
    Scott CF, Sinha D, Seaman FS, Walsh PN, Colman RW.
    Blood; 1984 Jan 15; 63(1):42-50. PubMed ID: 6606454
    [Abstract] [Full Text] [Related]

  • 9. A new assay for high molecular weight kininogen in human plasma using a chromogenic substrate.
    Scott CF, Pixley RA, Colman RW.
    Thromb Res; 1987 Dec 15; 48(6):685-700. PubMed ID: 3501619
    [Abstract] [Full Text] [Related]

  • 10. Amidolytic assay of factor XI in human plasma--significance of kallikrein for the activity measured.
    Briseid K, Hoem NO, Johannesen S, Haug K.
    Thromb Res; 1995 May 01; 78(3):239-50. PubMed ID: 7631304
    [Abstract] [Full Text] [Related]

  • 11. A comparison of the abilities of plasma kallikrein, beta-Factor XIIa, Factor XIa and urokinase to activate plasminogen.
    Miles LA, Greengard JS, Griffin JH.
    Thromb Res; 1983 Feb 15; 29(4):407-17. PubMed ID: 6344314
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. A low molecular weight platelet inhibitor of factor XIa: purification, characterization, and possible role in blood coagulation.
    Cronlund AL, Walsh PN.
    Biochemistry; 1992 Feb 18; 31(6):1685-94. PubMed ID: 1737024
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Major inhibitors of the contact phase coagulation factors.
    Schapira M.
    Semin Thromb Hemost; 1987 Jan 18; 13(1):69-78. PubMed ID: 2436302
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Inactivation of human plasma kallikrein and factor XIa by protein C inhibitor.
    Meijers JC, Kanters DH, Vlooswijk RA, van Erp HE, Hessing M, Bouma BN.
    Biochemistry; 1988 Jun 14; 27(12):4231-7. PubMed ID: 2844223
    [Abstract] [Full Text] [Related]

  • 19. Synthesis of tripeptide chloromethyl ketones and examination of their inhibitory effects on plasmin and plasma kallikrein.
    Tsuda Y, Teno N, Okada Y, Wanaka K, Bohgaki M, Hijikata-Okunomiya A, Okamoto U, Naito T, Okamoto S.
    Chem Pharm Bull (Tokyo); 1989 Nov 14; 37(11):3108-11. PubMed ID: 2534361
    [Abstract] [Full Text] [Related]

  • 20. Interaction of trypsin, beta-factor XIIa, and plasma kallikrein with a trypsin inhibitor isolated from barley seeds: a comparison with the corn inhibitor of activated Hageman factor.
    Chong GL, Reeck GR.
    Thromb Res; 1987 Oct 15; 48(2):211-21. PubMed ID: 3501175
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 19.